As we age, or simply inevitable over the years, several changes may occur on our skin and underlying tissues that we all like to avoid or delay as much as possible and, when they appear, at least correct or mitigate, if possible, without major interventions or changes in our appearance.

Therefore, the Dermatology come not only patients with more or less serious may become psoriasis or lupus, but also patients with medical and aesthetic problems, such as different types of dyschromias or discoloration of the skin: pigmented stains or dark (solar or senile lentigines, seborrheic keratosis, or warts, etc.), lighter or whitish spots (like confetti hypopigmentation, often in extremities), trauma, reddish or bluish vascular (spider veins, variculas and telangiectasia, ruby points, cuperosis and more advanced forms of rosacea, etc).

Facial rejuvenation treatments

In some people more than others, according to both our genetic and environmental factors, there are different brands of aging, which are visible in certain anatomical areas like the face, neck, and chest or back of hands. So it is with wrinkles and furrows of the face, to give them funny names and growing everyday use. No longer just talking about the crow’s feet, but more people knows what the barcode or marionette lines. And more and more patients are aware that these lines and wrinkles treated with botulinum toxin, popularly known as Botox ®, or hyaluronic acid fillers, collagen or other biocompatible materials. Thus, another reason for consultation, both women and, increasingly, men, is the treatment of the signs of sagging and flaccid in the face and neck, loss of volume in cheeks, the thinning of the lips, etc.

The marking of the passage of time on our bodies and our skin may not matter or affect us at all, but many people are completely normal impact on their way to see and even in his state of mind and his way of relating to others. Hence the importance of a serious and rigorous approach to these problems, seeking the most appropriate treatment, always personalized, and above all, with caution and common sense.

Signs of aging can be combated and prevented, at least in part, by measures such as healthy lifestyle (sun protection Mediterranean diet with high consumption of fruit and vegetables, night rest with adequate hours of sleep, avoid stress to the extent as possible, not smoking, avoiding drinks with high alcoholic content, etc). Then there is a broad range of treatment used to correct or mitigate some signs that reveal the inexorable passage of the years, ranging from the humble to the last peeling ablative or nonablative laser from simple moisturizer with tensor effect until Botox ® injections, from the cream with skin lightening effect to the most advanced laser ultrapulsed specific spots, or the common lipstick to profiling or filling the lips with injections of hyaluronic.

Everyone knows that your body changes when you get older, but almost everyone wants to look young and healthy as possible. To do this, better safe than sorry and, apart from the healthy lifestyle, if you have a problem or want to correct a small defect, it is best to treat in early stages, when you can achieve a more striking and satisfactory.

There are several reasons why men and women lose either experiencing hair thinning or hair hereditary baldness or call Androgenetic.

The baldness is the most common and caused by the harmful effects of dihydrotestosterone, or DHT in the scalp and hair. 90% cases of baldness in both men and women belong to this type of baldness.

Baldness caused by DHT is a common condition affecting approximately 50% of men and 30% of women.

The DHT is the combination result of enzyme 5-alpha reductase and testosterone. In hereditary baldness, DHT triggers a series of events that results in the miniaturization of follicles. Hair follicles in these becoming shorter, thinner and loses its coloration.

If nothing is done to block the DHT in time, the follicles eventually die and stop producing hair.

Hair loss may occur before 20 years old, but is more common than takes place between 20 and 30.

The amount of hair loss, and the size affected areas, tends to increase with time, this process often takes several years and even decades. It seems important immediate action before the onset of symptoms.

It is easier to block DHT and prevent the arrival of baldness than attempt to reverse a process that takes many years to evolve.

Now you can stop the fall and prevent baldness with hair thinning products. One of recommended products is biotin shampoo that is 100% natural with no side effects, highly effective, easy to use and appropriate both men and women who experience hair loss.

Expression of the baldness men

Androgenetic baldness in men starts with a thinning hair, and over time can result in receding hairline (entries) and clearance of the upper, middle or back of the head. Baldness, generally be classified as mild, moderate or severe and tends to follow a pattern which varies from person to person.

Expression of the baldness in women

In women, it manifests as a generalized thinning hair, especially on the top of the head. It is extremely rare that a woman loses all her hair.

In people who lived there is no reason not to continue experimenting and exercising the genital function, says Dr. Jose Antonio Florez, author of Self-Help Manual for a happy and healthy aging. In an interview published in the daily La Region de Orense, Florez said that “never disappears libido human, sexuality is so central to the elderly, it is a complete physical activity protects against diabetes, hypertension and cardiovascular disease. The physician explains that this is a manual that aims to set the tone for people to enjoy the natural phenomenon of life that is aging. The book, divided into topics relating to how to learn to age, physical activity, nutrition, prevention of depression, self esteem, sexuality or optimism, is directed not only to persons over 65 years, but especially youth and adolescents “The reality is that all right now we’re getting old” he says.

Florez explains that the first step to successful aging is to accept aging as a natural phenomenon of life, and then have a positive attitude in all circumstances. “Recent studies indicate the specialist-positive feelings make people vibrate with life, so the elderly living happy and humorous with an increase of eight years of life. In conclusion, happiness is the key to longevity. In contrast, loss of emotional support, love and the subsequent change of moving from a shared life to another in isolation, produces an emotional shock factor in the health of the elderly. The data support the conclusion that women more than men stand before the case of a breakdown or death of a loved one, which could explain the existence of a greater number of widows than widowers.

The book also offers tips to reduce depression and anxiety. Florez said that preventive medicine is the best weapon we have for our grandparents happy. In this regard notes that “the most important word that society must convey to the elderly is ‘useful’. “It would be appropriate to ask each of our elders what they want to do and give them the opportunity to participate. concludes.

An ill-fitting condom is not only more likely to break, but also reduces the pleasure of the couple, according to a study published this week in the medical journal British Medical Journal.

Researchers at the Kinsey Institute for Sex Research, Gender and Reproduction (U.S.) selected through newspaper ads and the blog of a brand of condoms to 436 men between 18 and 67, who answered a questionnaire on the use a condom in their last sex with women.

According to data from the survey, 45 percent of participants said that some of their relations over the past three months had used condoms that were not adjusted properly.

The difficulty in reaching orgasm for those who did not use condoms for their partners adjusted or multiplied by two when the size was not correct and the rate of those with rashes on the penis in their relationships was five times higher in those who did not use condoms of an appropriate size.

In addition, improper fit of condoms interfered when getting or maintaining an erection, breakage occurred at a frequency 2.5 times higher than when using a condom correctly and that the pair had made twice as likely to decide to remove the condom before completing intercourse.

The authors of this study, which raises the impact of ill-fitting condoms in sexual relations, acknowledged that the survey data are dependent on the veracity of the respondents’ answers.

For researchers, the possibility that the condom would reduce sexual pleasure may discourage couples from using protection, so they believe it would be “beneficial” to health authorities strive to “promote the improvement in the fit of condoms.

Study co-author, Bill Yarber, said that pornography has distorted body image, so that “no man would buy condoms labeled as small or very small”, hence the need for health authorities involved to raise awareness among couples in this regard. The new technology create crown skinless skin condoms that have high sensitive and can increase sexual pleasure in couple.

The new Plan Andaluz AIDS and other Sexually Transmitted Infections (2010-2015) includes among its public benefits make it difficult for patients suffering from lipodystrophy as a result of antiretroviral treatment, undergoing plastic surgery. This plan will also apply assisted reproduction techniques such as sperm washing, prevent the transmission of certain infectious diseases from parents to children for couples who decide to have offspring.

The use of plastic surgery aims, among other improvements, that does not stigmatize this group by their physical appearance, conditioned by the same treatments to undergo. This permits, Montero said that these people can “choose a better job, because at least they will not have problems of their appearance, towards the achievement of employment.

A team of researchers from the University of La Laguna has developed a system for providing anesthesia in surgical operations by means of a computer.

Through the system developed at the University of La Laguna is detected the patient’s hypnotic state at any time and provides the most appropriate dose of anesthesia, the academic center reported today in a statement.

Albino Juan Mendez, a researcher at the Anesthesia Control Group at the University of La Laguna, shows that with this system is individualized drug dose infused with the characteristics of each patient.

This group of researchers has developed a software tool, along with the team of anesthesiologists at the Hospital Universitario de Canarias, to facilitate the work of these health professionals.

The research has been published in the journal Computer Methods in Biomechanics and Biomedical Engineering.

Through sensors and a monitor, the system records the electroencephalogram (EEG) of patient and bispectral index (BIS), a unitless parameter that quantifies the hypnotic state and is related to the level of consciousness.

The bispectral index value between 100 (high alert as possible) and 0 (absence of cortical electrical activity, the more profound state of unconsciousness).

This research focuses on the region of bispectral index for general anesthesia, ie between 40 and 60.

The data are processed on a computer that includes specific control software and can act on the pump that injects the anesthetic to regulate their numbers.

The software is based on algorithms PID (Proportional Integral Derivative) adapter, a feedback control mechanism that automatically calculates the appropriate dosage based on measured and desired values.

To validate the technique the researchers have successfully performed simulations with various models developed by them and in addition the fifteen patients have been tested in volunteers, aged between 30 and 60, the Hospital Universitario de Canarias.

Preliminary results for both operating room and in simulation show that the system provides a satisfactory performance and applicability in the operating room with reasonable expectations of success, Albino said Mendez.

Scientists hope that the method helps to improve operational performance at the time of anesthetic dose and optimize patient recovery times and reduce the costs of interventions.

The study is a commonly used anesthetic, propofol, but could use others, such as isoflurane.

The technique also has application in the regulation of other physiological variables such as blood glucose level, temperature or blood pressure.

Alopecia areata is falling relatively quickly, the hair of various parts of our body, forming plaques or patches of alopecia, well circumscribed, usually single and round, but may be multiple and extensive, confluent or not. It can affect the scalp hair of the beard area, eyebrows, eyelashes, axilla, pubis, etc. It may even bring down the entire body hair (alopecia universalize).

This is a common reason for consulting a dermatologist, where you have to make a differential diagnosis with other diseases such as fungal infections (ringworm) or trichotillomania (hair pulling habit of continually) to avoid malpractice and, in the best, only useless.

A curious thing happens in alopecia areata is initially white hair respects people who already had white hair before the disease. However, if the disease persists, gray hair is also falling. Moreover, when the hair starts to reappear, it is initially white or lighter than normal, and then acquires its normal pigmentation.

The extent or degree of impact of alopecia areata is probably the most important prognostic factor, so that in the case of total alopecia (falling to 100% of scalp hair) or universal (100% drop of scalp and body) the possibility of complete cure is less than 10%.

Alopecia areata is associated with an increased frequency of other diseases, such as alterations in the nails (occur in up to two thirds of cases of alopecia areata), with autoimmune diseases (especially thyroid problems), atopic dermatitis (incidence is twice that in the general population) or even psychiatric or psychological disorders (such as anxiety or depression). Stress has often been cited as a cause of alopecia areata, although when controlled trials are designed, they have not always provided conclusive data. Although some studies have confirmed that stressful life events may precede episodes of alopecia areata, others have failed to demonstrate such a correlation. What seems clear is that the nervous system is closely related to our skin, and that how we react to stressful situations (in the broad sense) can influence and modulate the appearance of skin diseases, including alopecia areata. This has been demonstrated even in models of alopecia areata in mice which investigated the hypothalamic-pituitary-adrenal axis and its changes related to sustained stress.

Although there is a wide range of available treatments for alopecia areata (intralesional and topical corticosteroids, topical minoxidil, PUVA therapy, bexarotene, or any use of the best hair regrowth products …), since there are spontaneous remissions in 33% -50% of cases within one year from the start of injuries, other potential attitudes is to explain the patient’s illness and not perform any drug treatment. Psychotherapy and stress management methods can be useful in some cases.

In a study published in the journal Science 24 October 2003, the New York Breast Cancer Study Group (New York Group for the study of breast cancer) not only confirms that every woman carries a mutation in the genes BRCA1 and BRCA2 is at a high risk of breast cancer but, against what had been held so far of this risk involving women from families with low breast cancer or those who have inherited the mutant gene from his father.

For this reason is very important that women try to get as much information as possible about whether there had been breast cancers in young women not only in the maternal family, but his father’s family (which can inherit a BRCA gene mutation).

In practice only under investigation are those women who develop breast cancer at an early age or relatives who developed breast cancer or ovarian cancer when they were young.

The women included in the study were Jewish “Ashkenazi”, an ethnic group that includes 90% of the six million Jews living in the U.S. The researchers chose this population because mutations that occur more often in this group have been identified, making genetic testing have been more easily done. However, in view of the Dr. Mari-Claire King, Director of the study, the findings apply to all women with BRCA gene mutations.

The study shows that at the age of 80 years, a woman with a mutation in one of the two BRCA genes has endured a 82% risk of developing breast cancer, whereas in women without this mutation the average risk of developing breast cancer at age 80 is around 13%.

Broken down by decades of his life is a risk that a woman with BRCA1 or BRCA2 breast cancer development is as follows:

At the age of 40 years ——– 20%
At the age of 60 years ——– 55%
At the age of 80 years ——– 82%

Although similar numbers of risk had been already published in previous studies, those figures were merely estimates, while the results of the study published in Science are based on diagnoses of breast cancer and genetic determinations performed in 104 women carrying mutations in BRCA genes and more than 800 relatives of these women.

A new study finds that women who carry BRCA gene mutations have the same mortality rates for malignancies those women who do not have this variant DNA.

These findings were published in the July 12 edition of New England Journal of Medicine, and contradict much of the current medical belief.

“Our main finding that female carriers have similar survival rates, or even better, partly undermined, though not all, previous publications on the subject,” noted study author Dr. Gad Rennert, National Center Clalit for cancer control and Caramel Medical Center in Haifa, Israel. “However, we use a design ‘clean’ it was not possible for other research groups and therefore the results of our study is closer to ‘truth’ than any other study on the issue.”

Practically speaking, the findings may impact treatment decisions for women who have one of two genetic mutations, called BRCA1 or BRCA2.

Many previous studies on the subject have suggested that the cancer that resulted from these mutations had a worse prognosis than other types of breast tumors.

BRCA mutations are more common among Ashkenazi Jewish women, which could help determine why breast cancer is the leading cause of all deaths from cancer among Israeli women. About 60 percent of Israeli Jews are Ashkenazi. About 2 percent of all women of Ashkenazi origin and 12 percent of Ashkenazi women with breast cancer carry one of these two mutations.

Breast cancers associated with BRCA1, in particular, tend to occur in younger women, are high grade and are not estrogen receptor-positive and all these factors are associated with a worse outcome.

However, the information about how BRCA status would affect a woman’s prognosis had been “inconsistent,” wrote the authors.

To clarify the picture, the authors analyzed all cases of invasive breast cancer diagnosed between 1 January 1987 and 31 December 1988 and registered in the Israeli National Center for registration. This accounted for the majority of women who had been diagnosed with breast cancer in Israel during that time period. The researchers examined tumor samples from patients and analyzed DNA, and also categorized the deaths over 10 years from diagnosis.

The authors were able to analyze the tumor samples of 1.794 and 2.514 participants obtained the medical records of 1,545 women. Ten percent of participants who were Ashkenazi Jewish had a BRCA1 or BRCA2.

The risk of dying from breast cancer was not significantly different among carriers and non-carriers, the researchers found. Moreover, both groups responded similarly well to chemotherapy.

“The importance of the study is that it demonstrates that despite the profile of prognostic factors, the carriers of [BRCA] get good results, something that is important for female carriers and doctors,” said Rennert. “It also demonstrates that chemotherapy is very effective in the carriers and that oncologists should not deny to the carriers, even with small tumors, the potential benefits of treatment.”

The next step is to customize treatments, “as it is likely that some treatments work best for carriers, while others may be resistant,” said Rennert.

A current alternative for the management of patients with breast cancer has been the study of the BRCA gene (BRCA 1 and BRCA 2), as a hereditary mutation is present in approximately 5 to 8% of cases. The risk of breast cancer increases significantly in women with BRCA 1 and BRCA 2 mutant. These genetic mutations also influence the onset of ovarian cancer with an association of about 5% of cases, particularly associated with BRCA 1.

The clinical management of these findings must be guided through a detailed medical history in which clearly must include a family history of cancer and age of onset (at least 2 generations including parenting), the development of genetic counseling and implementation of clearly defined protocols, together with appropriate treatment options and the strict surveillance of family members considered as risk group.

For the first time, a team of Canadian researchers have calculated the risk for women who do not have a faulty BRCA gene, but close relatives who have had a cancer of that type.

Women who inherit a faulty BRCA1 or BRCA2 have a 80 percent chance of developing breast cancer sometime in her life.

But experts also know that families exist in other genes associated with the disease.

The team from the University of Toronto led by Steven Naron, studied women who had a first degree relative less than fifty years with cancer and three of any age who suffer from the same condition.

Despite not having a defective gene, more than one in three of these women developed breast cancer compared with an average probability of one in nine among the general population.

Although the risk of developing breast cancer among this group of women is not as high as among those who carry the gene (defective) is significant enough for doctors to consider applying appropriate preventive therapies.

It’s the first time it has measured the risk of breast cancer in this group of women, and significantly higher than the general population, so it is important that appropriate measures be considered.

The Canadian study published in the new issue of British Journal of Cancer.

According to Professor Jack Cuzick, an epidemiologist from Cancer Research UK, about 15 percent of British women suffering breast cancer have a family history of disease.